Luxturna 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
R/0040 
Renewal of the marketing authorisation. 
25/05/2023 
24/07/2023 
SmPC, 
Labelling and 
PL 
PSUSA/10742
Periodic Safety Update EU Single assessment - 
23/02/2023 
26/04/2023 
SmPC 
Refer to Scientific conclusions and grounds recommending 
/202207 
voretigene neparvovec 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10742/202207. 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
 
 
 
 
 
IB/0038/G 
This was an application for a group of variations. 
22/02/2023 
n/a 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
IA/0039 
A.7 - Administrative change - Deletion of 
19/01/2023 
n/a 
manufacturing sites 
IB/0034/G 
This was an application for a group of variations. 
03/11/2022 
n/a 
B.II.d.1.a - Change in the specification parameters 
and/or limits of the finished product - Tightening of 
specification limits 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
IA/0037 
B.II.b.5.a - Change to in-process tests or limits 
17/10/2022 
n/a 
applied during the manufacture of the finished 
product - Tightening of in-process limits 
IA/0035 
B.II.b.5.a - Change to in-process tests or limits 
17/10/2022 
n/a 
applied during the manufacture of the finished 
product - Tightening of in-process limits 
Page 2/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0033 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
19/08/2022 
26/04/2023 
SmPC 
life of the finished product - As packaged for sale 
(supported by real time data) 
IB/0032 
B.I.a.2.a - Changes in the manufacturing process of 
28/07/2022 
n/a 
the AS - Minor change in the manufacturing process 
of the AS 
IB/0031 
B.II.b.2.a - Change to importer, batch release 
27/06/2022 
n/a 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
IA/0030 
B.II.z - Quality change - Finished product - Other 
07/06/2022 
n/a 
variation 
IB/0029/G 
This was an application for a group of variations. 
31/05/2022 
n/a 
B.II.z - Quality change - Finished product - Other 
variation 
B.I.z - Quality change - Active substance - Other 
variation 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
Page 3/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II/0026/G 
This was an application for a group of variations. 
22/04/2022 
n/a 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.z - Quality change - Active substance - Other 
variation 
IB/0028 
C.I.11.z - Introduction of, or change(s) to, the 
28/02/2022 
n/a 
To update the RMP with `vision loss due to progressive 
obligations and conditions of a marketing 
authorisation, including the RMP - Other variation 
chorioretinal atrophy' as an important potential risk in the 
RMP. In addition the MAH has taken the opportunity to 
make minor administrative and template-related changes 
to the RMP. 
PSUSA/10742
Periodic Safety Update EU Single assessment - 
10/02/2022 
n/a 
PRAC Recommendation - maintenance 
/202107 
voretigene neparvovec 
PSUSA/10742
Periodic Safety Update EU Single assessment - 
16/09/2021 
09/11/2021 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
/202101 
voretigene neparvovec 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10742/202101. 
IB/0024/G 
This was an application for a group of variations. 
27/10/2021 
n/a 
B.I.d.1.z - Stability of AS - Change in the re-test 
period/storage period or storage conditions - Other 
variation 
Page 4/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.b.2.z - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
variation 
IAIN/0027/G 
This was an application for a group of variations. 
18/10/2021 
n/a 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
IB/0023 
B.II.b.4.f - Change in the batch size (including batch 
22/07/2021 
n/a 
size ranges) of the finished product - The scale for a 
biological/immunological medicinal product is 
increased/decreased without process change (e.g. 
duplication of line) 
IA/0021/G 
This was an application for a group of variations. 
04/03/2021 
n/a 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
A.7 - Administrative change - Deletion of 
manufacturing sites 
PSUSA/10742
Periodic Safety Update EU Single assessment - 
11/02/2021 
n/a 
PRAC Recommendation - maintenance 
/202007 
voretigene neparvovec 
Page 5/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IA/0020 
A.6 - Administrative change - Change in ATC 
16/12/2020 
09/11/2021 
SmPC and PL 
Code/ATC Vet Code 
PSUSA/10742
Periodic Safety Update EU Single assessment - 
17/09/2020 
20/11/2020 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
/202001 
voretigene neparvovec 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/10742/202001. 
IB/0018/G 
This was an application for a group of variations. 
05/11/2020 
n/a 
B.II.c.1.b - Change in the specification parameters 
and/or limits of an excipient - Addition of a new 
specification parameter to the specification with its 
corresponding test method 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.I.a.1.z - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - Other 
variation 
IB/0017 
B.I.b.2.e - Change in test procedure for AS or 
21/10/2020 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
IB/0015/G 
This was an application for a group of variations. 
03/08/2020 
n/a 
B.I.z - Quality change - Active substance - Other 
variation 
B.I.z - Quality change - Active substance - Other 
variation 
B.I.z - Quality change - Active substance - Other 
Page 6/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
variation 
B.I.z - Quality change - Active substance - Other 
variation 
IA/0014/G 
This was an application for a group of variations. 
29/05/2020 
n/a 
B.I.d.1.c - Stability of AS - Change in the re-test 
period/storage period or storage conditions - Change 
to an approved stability protocol 
B.I.d.1.c - Stability of AS - Change in the re-test 
period/storage period or storage conditions - Change 
to an approved stability protocol 
B.II.f.1.e - Stability of FP - Change to an approved 
stability protocol 
IB/0012/G 
This was an application for a group of variations. 
11/03/2020 
n/a 
B.I.a.1.z - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - Other 
variation 
B.I.a.1.z - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - Other 
variation 
PSUSA/10742
Periodic Safety Update EU Single assessment - 
13/02/2020 
n/a 
PRAC Recommendation - maintenance 
/201907 
voretigene neparvovec 
IB/0011/G 
This was an application for a group of variations. 
20/12/2019 
09/03/2020 
SmPC and PL 
B.I.d.1.a.4 - Stability of AS - Change in the re-test 
period/storage period - Extension or introduction of a 
Page 7/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
re-test period/storage period supported by real time 
data 
B.I.d.1.c - Stability of AS - Change in the re-test 
period/storage period or storage conditions - Change 
to an approved stability protocol 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
life of the finished product - As packaged for sale 
(supported by real time data) 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
life of the finished product - As packaged for sale 
(supported by real time data) 
B.II.f.1.e - Stability of FP - Change to an approved 
stability protocol 
IA/0010 
B.I.a.4.c - Change to in-process tests or limits 
19/12/2019 
n/a 
applied during the manufacture of the AS - Deletion 
of a non-significant in-process test 
IB/0009/G 
This was an application for a group of variations. 
18/12/2019 
n/a 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.II.d.1.c - Change in the specification parameters 
and/or limits of the finished product - Addition of a 
new specification parameter to the specification with 
its corresponding test method 
Page 8/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IAIN/0008 
B.II.b.2.c.1 - Change to importer, batch release 
23/10/2019 
n/a 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
IB/0006/G 
This was an application for a group of variations. 
20/09/2019 
n/a 
B.II.z - Quality change - Finished product - Other 
variation 
B.I.z - Quality change - Active substance - Other 
variation 
B.I.a.1.k - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - New 
storage site of MCB and/or WCB 
PSUSA/10742
Periodic Safety Update EU Single assessment - 
05/09/2019 
n/a 
PRAC Recommendation - maintenance 
/201901 
voretigene neparvovec 
IB/0004 
B.II.b.2.a - Change to importer, batch release 
24/04/2019 
n/a 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
IB/0003 
B.II.a.3.b.1 - Changes in the composition 
03/04/2019 
n/a 
(excipients) of the finished product - Other excipients 
- Any minor adjustment of the quantitative 
composition of the finished product with respect to 
excipients 
Page 9/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IAIN/0002/G 
This was an application for a group of variations. 
28/03/2019 
09/03/2020 
Annex II and 
PL 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
T/0001 
Transfer of Marketing Authorisation 
20/12/2018 
23/01/2019 
SmPC, 
Labelling and 
PL 
Page 10/10 
 
 
 
 
 
 
 
 
 
 
 
